GIST-T1 In Vitro Protein Carbonylation Detection Assay (Oxidative Stress)
CAT#: ITS-1122-YF2902
Target Cell Organism: Human
Target Cell Name: GIST-T1
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide GIST-T1-based In Vitro Protein Carbonylation Detection Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
GIST-T1
Target Cell Organism
Human
Target Cell Background
A new human cell line, GIST-T1, was established from a metastatic plural tumor from a gastrointestinal stromal tumor (GIST) of the stomach in a Japanese woman, and was characterized by immunohistochemistry, conventional banding methods, comparative genomic hybridization (CGH), and fluorescence in situ hybridization (FISH).
Related Diseases
Gastrointestinal Stromal Tumor; GIST
Research Area
Oncology
Assay Name
In Vitro Protein Carbonylation Detection Assay (Oxidative Stress)
Short Description
GIST-T1-cell based In Vitro Protein Carbonylation Detection Assay (Oxidative Stress)
Assay Description
Assays for the detection of protein carbonylation have widely been used to determine oxidative stress. Protein carbonylation is one of the irreversible protein modification processes in oxidative stress, which includes modification of side chains of amino acids of proteins to carbonyl derivatives. A wide variety of assays and analytical techniques such as high-performance liquid chromatography (HPLC), gas chromatography, immunoassays, radioactive labeling and capillary electrophoresis have been used to detect protein carbonylation in oxidative stress.
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.